MDC.L Live signaler | Maksimer profitt med Getagraph.com

Live Chart Being Loaded With Signals

Commentary (26 mai 2023 @ 12:40):

Stats
Dagens volum	450.00
Gjennomsnittsvolum	3.85M
Markedsverdi	3.69B
EPS	£0 ( 2023-11-14 )
Last Dividend	£3.00 ( 2022-08-04 )
Next Dividend	£0 ( N/A )
P/E	21.78
ATR14	£1.585 (0.32%)

Volum Korrelasjon

Lang: 0.13 (neutral)

Kort: -0.04 (neutral)

Signal:(60.912) Neutral

Mediclinic International Korrelasjon

10 Mest positive korrelasjoner

10 Mest negative korrelasjoner

Visste du det?

Korrelasjon er en statistisk måling som beskriver forholdet mellom to variabler. Den varierer fra -1 til 1, hvor -1 indikerer en perfekt negativ korrelasjon (hvor en variabel øker, går den andre ned), 1 indikerer en perfekt positiv korrelasjon (hvor en variabel øker, går den andre også opp), og 0 indikerer ingen korrelasjon (det er ingen forhold mellom variablene).

Korrelasjon kan brukes til å analysere forholdet mellom to variabler, ikke bare aksjer. Det er vanligvis brukt innen områder som finans, økonomi, psykologi, og mer.

Mediclinic International Korrelasjon - Valuta/Råvare

0.08
( neutral )

0.22
( neutral )

-0.07
( neutral )

-0.09
( neutral )

0.68
( moderate )

-0.34
( neutral )

Mediclinic International Økonomi

Annual	2022
Omsetning:	£3.23B
Bruttogevinst:	£505.00M (15.62 %)
EPS:	£0.210

FY	2022
Omsetning:	£3.23B
Bruttogevinst:	£505.00M (15.62 %)
EPS:	£0.210

FY	2021
Omsetning:	£3.00B
Bruttogevinst:	£426.00M (14.22 %)
EPS:	£0.0920

FY	2020
Omsetning:	£3.08B
Bruttogevinst:	£1.12B (36.43 %)
EPS:	£-0.434

Financial Reports:

No articles found.

Mediclinic International Dividends

(Q3/22)	(Q4/22)	(Q1/23)	(Q2/23)	(Q3/23)	(Q4/23)	(Q1/24)	(Q2/24)	(Q3/24)	(Q4/24)
£3.00 (N/A)	£0 (N/A)	£0 (N/A)	£0 (N/A)	£0 (N/A)	£0 (N/A)	£0 (N/A)	£0 (N/A)	£0 (N/A)	£0 (N/A)

Mediclinic International Dividend Information - Ex Dividend Junior

Dividend Sustainability Score: 8.34 - good (83.45%) | Divividend Growth Potential Score: 4.50 - Potential for dividend initiation, but uncertain (10.07%)

Very Unsafe

High risk of being cut

Unsafe

Heightened risk of being cut

Borderline

Moderate risk of being cut

Safe

Unlikely to be cut

Very Safe

Very unlikely to be cut

Information

First Dividend	£5.24	2016-06-16
Last Dividend	£3.00	2022-08-04
Next Dividend	£0	N/A
Payout Date	2022-08-26
Next Payout Date	N/A
# dividends	9	--
Total Paid Out	£35.14	--
Avg. Dividend % Per Year	0.19%	--
Score	2.59	--
Div. Sustainability Score	8.34
Div.Growth Potential Score	4.50
Div. Directional Score	6.42	--

Next Divdend (Est)
(2024-11-04)

£0 Estimate 0.00 %

Dividend Stability

0.06 Very Bad

Dividend Score

2.59

Pay Frequency

Annually

Yearly Payout

Year	Amount	Yield
2016	£0	0.00%
2017	£0	0.00%
2018	£7.90	1.17%
2019	£7.90	2.50%
2020	£0	0.00%
2021	£0	0.00%
2022	£3.00	0.94%
2023	£0	0.00%
2024	£0	0.00%

Dividend Commentary

The company's strong Dividend Sustainability Score (DSS) indicates its robust capacity to uphold current dividend levels. Unfortunately, its low Dividend Growth Potential Score (DGPS) suggests limited prospects for dividend growth. On the whole, the dividend outlook remains neutral, meriting close observation of both the company's financial health and growth prospects.

Top 10 dividend Companies for LSE

Symbol	Title	Last dividend	Frequency	Years Dividend	Yearly Dividend
UTG.L	Dividend Knight	2023-09-14	Annually	25	1.82%
MNP.L	Dividend Knight	2023-07-06	Quarterly	35	0.71%
DFS.L	Dividend Knight	2023-11-30	Annually	10	1.89%
SGE.L	Dividend Knight	2023-06-01	Semi-Annually	32	1.64%
IEML.L	No Dividend Player	2023-08-10	Insufficient data to determine frequency	2	1.30%
BME.L	Dividend King	2023-06-29	Semi-Annually	11	4.74%
XPP.L	Dividend Knight	2023-09-07	Quarterly	18	1.72%
NWOR.L	Dividend Knight	2023-06-01	Insufficient data to determine frequency	2	0.88%
ENT.L	Dividend Junior	2023-08-17	Annually	19	0.58%
SRE.L	Dividend Knight	2023-07-13	Semi-Annually	18	2.26%

Dividend Sustainability Score (DSS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
netProfitMarginTTM	0.0467	1.500	9.07	10.00	[0 - 0.5]
returnOnAssetsTTM	0.0210	1.200	9.30	10.00	[0 - 0.3]
returnOnEquityTTM	0.0507	1.500	-0.548	-0.822	[0.1 - 1]
payoutRatioTTM	0	-1.000	0	0	[0 - 1]
currentRatioTTM	1.791	0.800	6.04	4.84	[1 - 3]
quickRatioTTM	0.656	0.800	-0.846	-0.677	[0.8 - 2.5]
cashRatioTTM	0.649	1.500	7.51	10.00	[0.2 - 2]
debtRatioTTM	0.359	-1.500	4.01	-6.02	[0 - 0.6]
interestCoverageTTM	4.52	1.000	9.44	9.44	[3 - 30]
operatingCashFlowPerShareTTM	0.751	2.00	9.75	10.00	[0 - 30]
freeCashFlowPerShareTTM	0.509	2.00	9.75	10.00	[0 - 20]
debtEquityRatioTTM	0.833	-1.500	6.67	-10.00	[0 - 2.5]
grossProfitMarginTTM	0.156	1.000	-0.730	-0.730	[0.2 - 0.8]
operatingProfitMarginTTM	0.0866	1.000	-0.268	-0.268	[0.1 - 0.6]
cashFlowToDebtRatioTTM	0.214	1.000	9.92	9.92	[0.2 - 2]
assetTurnoverTTM	0.449	0.800	-0.343	-0.274	[0.5 - 2]
Total Score				8.34

Dividend Growth Score (DGS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
peRatioTTM	24.46	1.000	7.63	0	[1 - 100]
returnOnEquityTTM	0.0507	2.50	-0.352	-0.822	[0.1 - 1.5]
freeCashFlowPerShareTTM	0.509	2.00	9.83	10.00	[0 - 30]
dividendYielPercentageTTM	0	1.500	0	0	[0 - 0.4]
operatingCashFlowPerShareTTM	0.751	2.00	9.75	10.00	[0 - 30]
payoutRatioTTM	0	1.500	0	0	[0 - 1]
pegRatioTTM	19.07	1.500	10.00	0	[0.5 - 2]
operatingCashFlowSalesRatioTTM	0.171	1.000	8.22	0	[0.1 - 0.5]
Total Score				4.50

Mediclinic International

Mediclinic International plc, together with its subsidiaries, operates private hospitals. The company offers specialist-orientated and multidisciplinary healthcare services under the Mediclinic and Hirslanden brand names. It operates 74 hospitals, 20 day case clinics, 22 outpatient clinics, 5 subacute hospitals, 2 mental health facilities, and 453 theatres with approximately 11,538 inpatient beds in Switzerland, South Africa, Namibia, the Middle East, and the United Kingdom. The company also provides treasury, hospital equipment and procurement, emergency medical, management, food and catering, healthcare management, and debt collection and related services; manages healthcare staff; and owns and manages properties. In addition, it engages in the intellectual property holding and medical store/procurement businesses. The company was founded in 1983 and is based in Stellenbosch, South Africa.